NAPB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.579600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.336600E-01
Normal-vs-Stage2
8.660000E-01
Normal-vs-Stage3
8.076200E-01
Normal-vs-Stage4
9.991600E-01
Stage1-vs-Stage2
9.871700E-02
Stage1-vs-Stage3
3.186400E-01
Stage1-vs-Stage4
3.876200E-01
Stage2-vs-Stage3
9.434200E-01
Stage2-vs-Stage4
8.467200E-01
Stage3-vs-Stage4
8.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.180400E-01
Normal-vs-AfricanAmerican
2.298800E-01
Normal-vs-Asian
2.866600E-01
Caucasian-vs-AfricanAmerican
1.367830E-02
Caucasian-vs-Asian
7.481600E-03
AfricanAmerican-vs-Asian
7.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.475600E-01
Normal-vs-Female
8.670400E-01
Male-vs-Female
8.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.132600E-01
Normal-vs-Age(41-60Yrs)
2.061800E-01
Normal-vs-Age(61-80Yrs)
9.390800E-01
Normal-vs-Age(81-100Yrs)
2.248600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.198800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.679600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.660400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.383200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.909620E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.415600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.401800E-01
Normal-vs-Daily Drinker
4.840600E-01
Normal-vs-Weekly Drinker
3.823200E-01
Normal-vs-Occasional Drinker
6.548800E-01
Normal-vs-Social Drinker
3.387600E-01
Non Drinker-vs-Daily Drinker
2.698200E-01
Non Drinker-vs-Weekly Drinker
7.186000E-01
Non Drinker-vs-Occasional Drinker
1.399380E-01
Non Drinker-vs-Social Drinker
2.346200E-01
Daily Drinker-vs-Weekly Drinker
2.291200E-01
Daily Drinker-vs-Occasional Drinker
8.738400E-01
Daily Drinker-vs-Social Drinker
6.196600E-01
Weekly Drinker-vs-Occasional Drinker
1.142210E-01
Weekly Drinker-vs-Social Drinker
2.119200E-01
Occasional Drinker-vs-Social Drinker
7.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.049400E-01
Normal-vs-Grade 2
1.284820E-01
Normal-vs-Grade 3
5.371900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.454200E-02
Grade 1-vs-Grade 3
2.770300E-02
Grade 1-vs-Grade 4
4.049400E-01
Grade 2-vs-Grade 3
5.101800E-01
Grade 2-vs-Grade 4
1.284820E-01
Grade 3-vs-Grade 4
5.371900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.868800E-01
Normal-vs-NonDiabetic
7.969800E-01
Diabetic-vs-NonDiabetic
1.217150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.042800E-01
Normal-vs-NoPancreatitis
8.494400E-01
Pancreatitis-vs-NoPancreatitis
2.047500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.627440E-01
Normal-vs-N1
9.039000E-01
N0-vs-N1
8.614100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.519600E-01
Normal-vs-TP53-NonMutant
4.363500E-02
TP53-Mutant-vs-TP53-NonMutant
2.636200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
